The Scientist

» bumble bees, immunology and disease/medicine

Most Recent

image: Analysis: Industry-Funded Honeybee Study Was “Misleading”

Analysis: Industry-Funded Honeybee Study Was “Misleading”

By | January 24, 2017

Statisticians debunk a 2013 study by scientists at a Swiss agrochemical company, which had reported that a neonicotinoid pesticide posed a low risk to honeybees.  

1 Comment

image: First Bumblebee Species Declared Endangered in U.S.

First Bumblebee Species Declared Endangered in U.S.

By | January 11, 2017

The federal government concludes the rusty patched bumblebee is nearing extinction.

0 Comments

image: Exploring the Epigenetics of Ethnicity

Exploring the Epigenetics of Ethnicity

By | January 11, 2017

Researchers attempt to estimate how much of the human genome’s methylation patterns can be attributed to genetic ancestry.

0 Comments

image: Contributors

Contributors

By | January 1, 2017

Meet some of the people featured in the January 2017 issue of The Scientist.

0 Comments

image: How an Invasive Bee Managed to Thrive in Australia

How an Invasive Bee Managed to Thrive in Australia

By | January 1, 2017

The Asian honeybee should have been crippled by low genetic diversity, but thanks to natural selection it thrived.

1 Comment

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

image: Naive T Cells Find Homes in Lymphoid Tissue

Naive T Cells Find Homes in Lymphoid Tissue

By | December 2, 2016

The human lymph nodes and spleen maintain unique, compartmentalized sets of naive T cells well into old age.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. Next Generation: Mobile Microscope Detects DNA Sequences
  2. Scientists Activate Predatory Instinct in Mice
  3. Lipids Take the Lead in Metastasis
  4. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
RayBiotech